-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0645-151012.pdf
August 05, 2015 - topic, including key questions, populations, interventions, comparators, and outcomes, will
be further developed
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0210_12-07-2009.pdf
January 01, 2009 - scope of this topic, including populations, interventions, comparators, and outcomes, will be further
developed
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0068_01-30-2009.pdf
January 01, 2009 - scope of this
topic, including populations, interventions, comparators, and outcomes, will be further developed
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0251_05-20-2010.pdf
January 01, 2010 - scope of this topic, including populations, interventions, comparators, and outcomes, will be further
developed
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0359_10-15-2010.pdf
January 01, 2010 - scope of this
topic, including populations, interventions, comparators, and outcomes, will be further developed
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0095_04-10-2009.pdf
January 01, 2009 - Selection Process & Next Steps
Noninvasive diagnosis of coronary artery disease in women will be developed
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0488_12-27-2011.pdf
January 01, 2011 - scope of this topic, including populations, interventions, comparators, and outcomes, will
be further developed
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0351_05-10-2010.pdf
January 01, 2010 - scope of this topic, including populations, interventions, comparators, and outcomes, will be further
developed
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0519_02-27-2012.pdf
January 01, 2012 - scope of this topic,
including populations, interventions, comparators, and outcomes, will be further developed
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0745-141009.pdf
September 03, 2014 - scope of this topic, including populations, interventions, comparators, and
outcomes, will be further developed
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-612-09-03-2013.pdf
January 01, 2013 - If this topic is developed into a technical brief, a protocol posted on the AHRQ Web site
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/machine-learning-quality_research.pdf
September 01, 2012 - As with lasso, this was developed on training data and then
used to predict out-of-sample citations … Predictions
The predictive model was first developed to differentiate relevant and irrelevant titles … No patient younger than 65 years developed a pressure
ulcer. … None of the 4 patients in the intervention group developed
pressure ulcers. … The mobile surgical service has been developed to help; partly to address this
issue as well as to
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/obesity-child_research-protocol.pdf
March 31, 2010 - the CDC in 2000.
13
In general, the values of the
two sets percentile are similar, but they were developed … Further, once developed, obesity is difficult to
treat (e.g., due to the 'set point theory').
27 … Various interventions for childhood obesity prevention and management have been developed
and assessed … healthy eating or increased physical activities or reduced
sedentary behaviors such as TV time), developed … systematic review and meta-analysis compared to previously published reviews based on
vigorously developed
-
effectivehealthcare.ahrq.gov/sites/default/files/14_substanceabuse_potential_high_impact_june_2012.pdf
January 01, 2012 - As topics are entered into the System, individual topic profiles are developed for
technologies and … AHRQ Healthcare
Horizon Scanning System implementation of a systematic horizon scanning protocol (developed … long-acting versions of currently used
pharmacotherapies (buprenorphine and naltrexone) have been developed … o Alkermes, plc (Dublin, Ireland), has developed an injectable, extended-release
formulation of naltrexone … Controlled Substances Act of 1970.
16
Titan Pharmaceuticals, Inc., (South San
Francisco, CA) recently developed
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/procalcitonin_research-protocol.pdf
September 08, 2011 - To classify observational study
designs, we used the system developed by Briss and colleagues
10
. … will use the National Library of Medicine’s Medical Subject
Headings (MeSH) keyword nomenclature developed … The EPC Methods Guide developed by the AHRQ EPC Program
18
will be used to
rate the strength of … The system used for rating the strength of the overall body
of evidence was developed by the AHRQ EPC … Program for the EPC Methods
Guide, based on a system developed by the GRADE Working Group
18
.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/dot-plots-methods.pdf
October 01, 2021 - Department of Health and Human Services endorsement of any derivative
products that may be developed … A Stata module developed by Phillips and colleagues is available to produce such dot plots
(https:// … ideas.repec.org/c/boc/bocode/s458735.html).3 However, the Stata module developed by
Phillips and colleagues
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-principles_methods.pdf
August 01, 2009 - AHRQ), the EHC Program Scientific
Resource Center, and the AHRQ Evidence-based Practice Centers have developed … practices.13
Through these approaches, we have identified concerns about inconsistent or poorly
developed … • A weakly developed approach to assessing the strength of evidence and a desire to begin
to reconcile … The five workgroups developed guidance on
observational studies, applicability, harms and adverse effects … identify pertinent clinical concerns that even expert
health professionals may overlook.8 AHRQ has developed
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/dot-plots-methods.pdf
October 01, 2021 - Department of Health and Human Services endorsement of any derivative
products that may be developed … A Stata module developed by Phillips and colleagues is available to produce such dot plots
(https:// … ideas.repec.org/c/boc/bocode/s458735.html).3 However, the Stata module developed by
Phillips and colleagues
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/scope-communicating-evolving-evidence-white-paper_0.pdf
June 01, 2025 - Department of Health and Human Services endorsement of any derivative
products that may be developed … The scope (inclusion/exclusion criteria) was developed with input from a Technical Expert Panel
(TEP … This visual dashboard, developed using the software program Tableau, shows pooled
results for benefits … A visual abstract based on our living review23 has been developed by the Systematically
Testing the … alternative styles of visualization, we also obtained feedback
from the TEP on the visual abstract developed
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antidepressants-update_research-protocol.pdf
July 13, 2011 - first-generation antidepressants (tricyclic antidepressants and
monoamine oxidase inhibitors) and more recently developed … Analytic Framework
Based on the key questions, we developed an analytic framework to guide the
comparative … Geographically, we will include all developed countries: United States, Canada, United
Kingdom, Europe … assess the quality (internal validity) of studies, we will use predefined criteria
based on those developed